Skip to Content

5 Results Found

  • Review
  • Open Access
557 Views
23 Pages

9 July 2026

Ebola virus disease (EVD) has traditionally been considered an acute infection characterized by high mortality and severe systemic inflammation. However, growing evidence accumulated over the last decade has progressively challenged this view, demons...

  • Review
  • Open Access
1,000 Views
27 Pages

Despite effective antiretroviral therapy, HIV persists in diverse tissue reservoirs that pose major barriers to a cure. This review examines the heterogeneous maintenance mechanisms of HIV reservoirs in lymph nodes, intestinal mucosa, and the central...

  • Review
  • Open Access
7 Citations
4,660 Views
10 Pages

Pathogenesis of Uveitis in Ebola Virus Disease Survivors: Evolving Understanding from Outbreaks to Animal Models

  • Caleb Hartley,
  • J. Clay Bavinger,
  • Sanjana Kuthyar,
  • Jessica G. Shantha and
  • Steven Yeh

Ebola virus disease (EVD) and emerging infectious disease threats continue to threaten life, prosperity and global health security. To properly counteract EVD, an improved understanding of the long-term impact of recent EVD outbreaks in West Africa a...

  • Article
  • Open Access
212 Views
34 Pages

Polyploid giant cancer cells (PGCCs) are increasingly recognized as major drivers of therapy resistance and tumor relapse, yet the conserved molecular programs underlying their persistence remain incompletely defined. To identify genes consistently d...

  • Review
  • Open Access
16 Citations
6,106 Views
26 Pages

Fighting HIV-1 Persistence: At the Crossroads of “Shoc-K and B-Lock”

  • Chiara Acchioni,
  • Enrico Palermo,
  • Silvia Sandini,
  • Marta Acchioni,
  • John Hiscott and
  • Marco Sgarbanti

20 November 2021

Despite the success of highly active antiretroviral therapy (HAART), integrated HIV-1 proviral DNA cannot be eradicated from an infected individual. HAART is not able to eliminate latently infected cells that remain invisible to the immune system. Vi...